Haematologists in Türkiye Report Strong Medicolegal Awareness but Persistent Fear of Legal Exposure
A cross-sectional survey of actively practicing adult haematologists in Türkiye found a striking gap between medicolegal awareness and perceived legal vulnerability. The study’s central message is clear: even when physicians understand the legal environment around clinical practice, that awareness does not necessarily ease concern. In haematology, where decisions often involve complex diagnostic pathways, prolonged treatment courses, transfusion support, and high-stakes risk-benefit judgments, that pressure can shape day-to-day care in ways that extend beyond the bedside.
The survey design focused on clinicians who were currently practicing, which strengthens the relevance of the responses to real-world care delivery. Before distribution, the questionnaire underwent cognitive pretesting with seven haematologists to assess clarity, comprehension, and interpretation. This step matters because medicolegal concepts can be interpreted differently depending on training, workplace setting, and prior exposure to complaints or litigation. A poorly constructed questionnaire would have blurred those distinctions; this one attempted to reduce that problem before data collection began.
The study used composite measures to evaluate medicolegal awareness, medicolegal exposure, and defensive medicine behaviours. That structure allowed the investigators to move beyond a simple yes-or-no assessment of legal concern. It separated knowledge from experience and from practice change, which is especially important in a field where fear of claims can influence consent discussions, investigation thresholds, referral patterns, and willingness to pursue aggressive therapy. High awareness does not necessarily mean low anxiety. In this cohort, the two travelled together.
Defensive Medicine in a Specialty Built on High-Stakes Judgment
Haematology is not a low-risk specialty. Treatment often depends on serial laboratory data, evolving diagnostic categories, and interventions that can carry both immediate and delayed harms. Decisions around anticoagulation, cytopenias, marrow disorders, bleeding risk, thrombosis prevention, transfusion thresholds, and disease-directed therapy can all become contentious if outcomes are poor. In that setting, legal caution can become embedded in routine practice, sometimes without being explicitly recognized by the clinician making the decision.
This survey sits inside a broader clinical reality: physicians do not only respond to disease biology, they also respond to the possibility of complaint, scrutiny, or litigation. Defensive medicine can take several forms, including extra testing, referral of uncertainty to tertiary centers, avoidance of high-risk cases, or more conservative treatment than clinical evidence alone would justify. The abstract points to medicolegal anxiety as a driver of such behaviours, and haematology offers a setting where that pattern could be particularly consequential because delays or restraint can matter just as much as over-treatment.
The study’s title captures the tension directly. Legal risk perception remained high despite high medicolegal awareness. That combination suggests that knowledge of the system does not necessarily translate into confidence within it. Physicians may understand reporting pathways, legal duties, or complaint mechanisms and still feel vulnerable. For patients, the bedside consequence can be subtle but important: decision-making may drift toward caution, documentation burden may expand, and complex cases may be handled with greater reluctance.
Survey Design, Interpretation, and the Limits of Self-Report
The methodology has several strengths, and it also carries clear constraints. The web-based cross-sectional design allowed access to practicing haematologists across Türkiye, but voluntary online participation introduces selection bias. Clinicians with stronger views about medicolegal risk may have been more likely to respond. The reliance on self-reported data also opens the door to recall bias and social desirability bias, particularly on questions that touch on sensitive professional conduct. A doctor may understate defensive behaviours or overstate familiarity with legal requirements, especially in a survey tied to professional identity.
The respondent mix also matters. The predominance of tertiary-care and early-to-mid-career physicians limits generalisability. Tertiary centers often manage more complex cases, more referrals, and more interdisciplinary conflict, all of which can amplify medicolegal concern. Early-career clinicians may also experience legal anxiety differently from senior physicians who have developed experience, institutional support, or a more stable clinical pattern. Those factors can shape survey responses in ways that are real but not necessarily universal across all haematology practice settings.
Even with those limitations, the study remains useful because it describes a professional environment in which awareness alone does not solve the problem. A clinician can know the legal terrain and still practice under pressure. In a specialty where treatment plans may involve cytotoxic therapy, transfusion decisions, marrow evaluation, or prolonged monitoring, the cost of uncertainty can be high. Fear of medicolegal exposure may influence not only individual decisions but also team culture, communication style, and the threshold for escalation.
What the Findings Mean for Haematology Practice
The practical implication is not that physicians should ignore medicolegal risk. It is that awareness and support must coexist. Risk education without institutional protection can leave clinicians better informed but no less afraid. Haematology departments and hospitals may need clearer protocols, stronger documentation systems, case review support, and legal literacy training that reflects the realities of specialty practice rather than generic compliance advice.
There is also a patient-care dimension. Defensive behaviour may appear protective, yet it can alter care pathways in ways that are not always beneficial. Extra testing can delay treatment. Excessive caution can weaken therapeutic momentum. Avoidance of complex cases can shift burden to tertiary centers and narrow access. Those downstream effects do not appear in a simple awareness score, but they are part of the clinical meaning of medicolegal fear.
This survey adds an important regional data point from Türkiye and contributes to a wider conversation about how legal climate shapes specialist practice. It does not measure harm directly, and it does not prove that defensive medicine changed outcomes in this cohort. It does show that haematologists can be highly aware of medicolegal issues while still perceiving substantial legal risk. The unanswered question is how best to reduce that fear without blunting appropriate accountability, and how to do so in a specialty where uncertainty is often part of the job.